Life Science PhD Meeting
FIND THE PHOTO PAGE April 22, 2022
COVID RULES
- 2G Event
- registration in person mandatory (registration Wednesday 13:00-19:00 and Thursday 8:00-9:00 Foyer CCB)
- FFP2 mandatory to all times
- we encourage you to get tested before the event
- keep distance
- use only the labelled seats in the lecture hall
- no food in the Foyer, only closed beverages
- stay in the mensa when you eat
The Life Science PhD Meeting Innsbruck 2022 will take place from the 20th to the 22nd of April, 2022 in CCB, Innrain 80-82, Innsbruck.
Event features:
– 6 outstanding plenary speakers
– 30 short presentations selected from submitted abstracts
– a “ Animal-free Research – Cell Models and Organoids ” workshop
– short talk and poster prizes
– a smashing party
Poster format is A0 (or smaller) in portrait format.
Short talk duration is 12 min + 3 min discussion.
Please write to phd-school@i-med.ac.at if you have any questions.
You can register for the meeting here: http://www.meduni-ibk.at/page.cfm?vpath=anmeldung&veranstaltung_fk=194
After the registration you will receive a mail with the attached abstract submission form (Registration Deadline 15.4.2022), if you are interested in a poster or short talk. Please beware that we have limited space for talks, so only the best abstracts will be granted a talk. If you are not selected for a talk, you will automatically get a poster or flashtalk slot. Send the abstract submission form to phd@i-med.ac.at
To participate in the workshop please register seperatly here: http://www.meduni-ibk.at/page.cfm?vpath=anmeldung&veranstaltung_fk=195
We like to thank our sponsors that enabled us to make this meeting free of charge and are looking forward to see many of you at the Life Science PhD Meeting Innsbruck 2022!
Peter Penzes
Northwestern University, Chicago, USA
“Regulation of synaptic architecture and function bei neurodevelopmental disorder risk factors”
https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=16355
Manuel Mayr
King’s College,
London
“Multiomics approaches for systems biology in human disease “
https://www.kcl.ac.uk/people/manuel-mayr
Ulrike Schleicher
Mikrobiologisches Institut,
Erlangen
“The arginase pathway and its immunoregulatory functions in infectious disease”
Jerome Mertens
Institute for Molecular Biology, University of Innsbruck
“Direct neuronal reprogramming of patient skin cells to study age-related neurodegeneration”
https://www.mertenslab.com/
Diether Lambrechts
KU Leuven Center of Cancer Biology,
Belgium
“Single-cell multi-omics profiling of the heterogeneous tumor micro-environment”
https://lambrechtslab.sites.vib.be/en
Charlotte Simmler
Mediterranean Institute of marine and terrestial Biodiversity and Ecology
“From Sponge Biology to Drug Discovery: an Interdisciplinary Symbiosis”
https://www.imbe.fr/charlotte-simmler.html
Animal-free Research – Cell Models and Organoids
Have you ever wondered, how your cells lining the respiratory tract and lung look like? Have you thought about their functions within the body and which cells do what? There are lot of fascinating things to do with human cell and tissue models, which might result in replacement of animal models also in pre-clinical research in the future. Therefore, it´s time to get active and move towards replacement by creating realistic model approaches for drug testing, infectious disease research and testing novel therapeutic options.
Keynote: ´The long and winding road from 2D to 3D culture to reduce and replace animal experimentation´
Meet Doris Wilflingseder, University Professor of Infection Biology and initiator of MUI animalFree Research Cluster
How does my respiratory system look like?
Learn about the markers used to characterize upper and lower respiratory tract and lung and stain these accordingly using fluorescently labeled antibodies. Analyse the stained samples by high content screening at the Institute of Hygiene and Medical Microbiology.
Networking and Question Time: Bring on your questions – we are here for you every step of the way!
The workshop is jointly organized by Univ.-Prof. Dr. Doris Wilflingseder, Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck
